InvestorsHub Logo
Followers 14
Posts 1669
Boards Moderated 0
Alias Born 02/06/2019

Re: None

Thursday, 12/10/2020 6:14:36 PM

Thursday, December 10, 2020 6:14:36 PM

Post# of 140478
a little OT, but possibly relevant... and as a disclaimer: I am still researching Titan for its 'prospects & potential' and the possible speed bumps it might encounter. Cause I do like the idea, but informed helps me make better decisions.. So just tossing this out, see what kind of comments if any it generates..

Titan CEO implied around 2 years before they see starting the pre-clinic phase of testing...

MDT is saying 2 years and they could be FDA approved. Around the time Titan would be ready to start its pre-clinical??

https://www.massdevice.com/medtronic-finally-unveils-its-new-robot-assisted-surgery-system/
Medtronic plans to launch the Hugo system in undisclosed places outside the U.S. early the next year, allowing the company to start gathering clinical data, White said. CE Mark and U.S. IDE submissions will follow later in the year, with a goal of achieving U.S. 510(k) clearance in about two years.

and while Hugo seems to be similar to the ISRG Da Vinci, could it do what Titan is looking to do??

kind of thinking if ISRG and MDT can do a variety of procedures with one unit...

while there could be 'room' for a single procedure unit such as Titan is working on (first effort is for a specific procedure, realizing there would be actions taken to expand the usage)

has me wondering... how many DIFFERENT surgical systems will the health care system be willing to 'support'?? IF MDT gets theirs thru the FDA for example, will there be room for more? Or an unfilled niche to fill? I just don't know, but have to ponder/ask..